|
|
anion transport
|
GO:0006820 |
177 |
0.357
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.244
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.238
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.216
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.212
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.193
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.189
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.187
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.184
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.184
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.182
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.180
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.180
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.176
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.174
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.170
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.169
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.168
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.168
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.164
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.158
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.156
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.155
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.154
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.148
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.148
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.147
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.145
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.134
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.134
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.127
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.125
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.123
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.119
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.116
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.115
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.115
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.109
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.106
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.105
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.104
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.102
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.101
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.097
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.096
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.093
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.092
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.092
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.092
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.092
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.088
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.088
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.086
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.081
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.080
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.079
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.078
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.077
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.077
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.077
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.077
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.076
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.075
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.075
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.074
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.074
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.074
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.073
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.073
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.073
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.072
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.072
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.070
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.070
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.070
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.069
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.069
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.067
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.066
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.066
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.065
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.064
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.064
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.063
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.061
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.061
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.060
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.060
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.059
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.059
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.059
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.059
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.058
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.058
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.058
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.057
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.057
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.056
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.055
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.055
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.055
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.055
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.054
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.054
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.054
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.054
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.054
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.054
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.053
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.053
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.052
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.052
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.052
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.052
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.052
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.051
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.051
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.051
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.051
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.051
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.050
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.049
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.049
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.049
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.049
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.049
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.048
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.048
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.048
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.048
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.048
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.048
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.047
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.047
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.047
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.046
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.046
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.046
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.045
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.045
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.045
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.045
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.044
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.044
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.044
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.043
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.043
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.043
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.043
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.043
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.043
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.042
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.042
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.042
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.042
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.041
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.041
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.041
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.041
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.041
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.041
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.040
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.040
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.040
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.040
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.039
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.039
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.039
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.039
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.039
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.039
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.039
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.039
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.038
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.038
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.038
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.038
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.038
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.038
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.038
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.038
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.038
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.037
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.037
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.037
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.037
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.036
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.036
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.036
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.036
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.036
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.036
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.036
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.036
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.036
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.036
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.035
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.035
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.035
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.034
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.034
|
|
|
|
cgmp biosynthetic process
|
GO:0006182 |
13 |
0.034
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.034
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.034
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.034
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.034
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.033
|
|
|
|
regulation of timing of cell differentiation
|
GO:0048505 |
11 |
0.033
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.033
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.033
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.033
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.033
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.033
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.033
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.033
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.033
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.033
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.033
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.033
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.032
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.032
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.032
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.031
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.031
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.031
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.031
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.031
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.031
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.031
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.031
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.031
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.030
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.030
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.030
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.030
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.030
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.030
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.029
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.029
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.029
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.029
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.029
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.029
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.029
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.029
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.029
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.028
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.028
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.028
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.028
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.028
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.028
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.028
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.028
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.028
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.028
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.028
|
|
|
|
catecholamine transport
|
GO:0051937 |
21 |
0.028
|
|
|
|
lung proximal distal axis specification
|
GO:0061115 |
1 |
0.028
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.028
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.028
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.028
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.028
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.027
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.027
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.027
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.027
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.027
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.027
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.027
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.027
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.027
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.027
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.027
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.026
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.026
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.026
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.026
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.026
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.026
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.026
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.026
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.026
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.026
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.026
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.026
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.026
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.026
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.026
|
|
|
|
positive regulation of fat cell proliferation
|
GO:0070346 |
1 |
0.026
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.026
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.026
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.026
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.026
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.026
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.025
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.025
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.025
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.025
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.025
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.025
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.025
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.025
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.025
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.025
|
|
|
|
lactation
|
GO:0007595 |
25 |
0.025
|
|
|
|
learning
|
GO:0007612 |
98 |
0.025
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.025
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.025
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.025
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.024
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.024
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.024
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.024
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.024
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.024
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.024
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.024
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.024
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.024
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.024
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.024
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.024
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.024
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.024
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.024
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.024
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.024
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.024
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.023
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.023
|
|
|
|
regulation of resting membrane potential
|
GO:0060075 |
3 |
0.023
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.023
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.023
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.023
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.023
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.023
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.023
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.023
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.023
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.023
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.023
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.023
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.023
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.023
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.022
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.022
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.022
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.022
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.022
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.022
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.022
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.022
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.022
|
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.022
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.021
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.021
|
|
|
|
regulation of isoprenoid metabolic process
|
GO:0019747 |
1 |
0.021
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.021
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.021
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.021
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.021
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.021
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.021
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.021
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.021
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.021
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.020
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.020
|
|
|
|
transforming growth factor beta receptor signaling pathway involved in primitive streak formation
|
GO:0090010 |
1 |
0.020
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.020
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.020
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.020
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.020
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.020
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.020
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.020
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.020
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.020
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.020
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.019
|
|
|
|
catecholamine biosynthetic process
|
GO:0042423 |
11 |
0.019
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.019
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.019
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.019
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.019
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.019
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.019
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.019
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.019
|
|
|
|
neural nucleus development
|
GO:0048857 |
22 |
0.019
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.019
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.019
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.019
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.019
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.019
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.019
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.019
|
|
|
|
lung pattern specification process
|
GO:0060432 |
1 |
0.019
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.019
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.018
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.018
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.018
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.018
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.018
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.018
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.018
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.018
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.018
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.018
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.018
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.018
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.018
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.018
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.018
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.018
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.018
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.018
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.018
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.018
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.018
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.018
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.018
|
|
|
|
regulation of g protein activated inward rectifier potassium channel activity
|
GO:1900128 |
1 |
0.018
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.018
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.018
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.018
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.018
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.017
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.017
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.017
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.017
|
|
|
|
male anatomical structure morphogenesis
|
GO:0090598 |
4 |
0.017
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.017
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.017
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.017
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.017
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.017
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.017
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.017
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.017
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.017
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.017
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.017
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.017
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.017
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.017
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.017
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.017
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.017
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.017
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.017
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
18 |
0.017
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.017
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.017
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.017
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.017
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.017
|
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.017
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.017
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.017
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.016
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.016
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.016
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.016
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.016
|
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.016
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.016
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.016
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.016
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.016
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.016
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.016
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.016
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.016
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.016
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.016
|
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.016
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.016
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.016
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.016
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.016
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.016
|
|
